Literature DB >> 200199

Inhibition of bovine leukemia virus release by antiviral antibodies.

D M Driscoll, M Onuma, C Olson.   

Abstract

Peripheral blood lymphocytes from bovine leukemia virus (BLV) infected cattle were grown in vitro with serums from BLV-infected and uninfected cattle, sheep and rabbits. Only serums from infected animals which had antibody to gp 45/55, the major glycoprotein antigen, inhibited the release of virus from the cells. Although viral antigens could be detected in the cells themselves, none were detected in the supernatants of cultures grown with these serums. Normal serums and serums with antibody only to p23, the internal BLV antigen, did not inhibit virus release. To identify the factor responsible for virus release inhibition, 2 inhibitory serums were absorbed with either gp 44/55, p23 or tissue culture cells from BLV-infected and uninfected cells lines. The results indicated that antibody to gp 45/55 is the factor responsible for virus release inhibition.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200199     DOI: 10.1007/bf01314487

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  15 in total

1.  Survey for antibodies to leukemia (C-type) virus in cattle.

Authors:  L E Baumgartener; C Olson; J M Miller; M J Van Der Maaten
Journal:  J Am Vet Med Assoc       Date:  1975-02-01       Impact factor: 1.936

2.  Replicating type-C virus particles in monolayer cell cultures of tissues from cattle with lymphosarcoma.

Authors:  M J Van Der Maaten; J M Miller; A D Boothe
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

3.  C-type particles in cultured lymphocytes from highly leukemic cattle.

Authors:  F Weiland; S Ueberschär; O C Straub; O R Kaaden; B Dietzschold
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

4.  Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin.

Authors:  N D Stock; J F Ferrer
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

5.  Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma.

Authors:  J M Miller; L D Miller; C Olson; K G Gillette
Journal:  J Natl Cancer Inst       Date:  1969-12       Impact factor: 13.506

6.  Properties of two isolated antigens associated with bovine leukemia virus infection.

Authors:  M Onuma; C Olson; D M Driscoll
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

7.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

8.  Inhibition of virus release by antibodies to surface antigens of influenza viruses.

Authors:  W R Dowdle; J C Downie; W G Laver
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

9.  In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures.

Authors:  D C Graves; J F Ferrer
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

View more
  7 in total

1.  Location of antigens associated with bovine leukemia virus.

Authors:  M Onuma; D M Driscoli; C Olson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.

Authors:  B Chesebro; K Wehrly; D Doig; J Nishio
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.

Authors:  Jing Jin; Nathan M Liss; Dong-Hua Chen; Maofu Liao; Julie M Fox; Raeann M Shimak; Rachel H Fong; Daniel Chafets; Sonia Bakkour; Sheila Keating; Marina E Fomin; Marcus O Muench; Michael B Sherman; Benjamin J Doranz; Michael S Diamond; Graham Simmons
Journal:  Cell Rep       Date:  2015-12-10       Impact factor: 9.423

4.  Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation.

Authors:  W A Ferens; C J Hovde
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.

Authors:  Masahiro Kajihara; Andrea Marzi; Eri Nakayama; Takeshi Noda; Makoto Kuroda; Rashid Manzoor; Keita Matsuno; Heinz Feldmann; Reiko Yoshida; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 6.  Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.

Authors:  Jing Jin; Graham Simmons
Journal:  Viruses       Date:  2019-03-28       Impact factor: 5.048

7.  Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors.

Authors:  Mehmet Sahin; Melissa M Remy; Benedict Fallet; Rami Sommerstein; Marianna Florova; Anna Langner; Katja Klausz; Tobias Straub; Mario Kreutzfeldt; Ingrid Wagner; Cinzia T Schmidt; Pauline Malinge; Giovanni Magistrelli; Shozo Izui; Hanspeter Pircher; J Sjef Verbeek; Doron Merkler; Matthias Peipp; Daniel D Pinschewer
Journal:  Cell Rep       Date:  2022-02-01       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.